![](https://investorshub.advfn.com/uicon/296219.png?cb=1502282888)
Thursday, April 13, 2023 3:06:03 PM
Mr. Katzaroff’s career as a serial entrepreneur began in high school , importing minerals and pewter from Brazil. After completing his degree at UC Santa Barbara, he started his financial career with Bateman Eichler, Smith Barney and EF Hutton. In 1998, be founded and began publishing, the “TriVest Financial Chronicles” newsletter, while also serving as a strategic funding consultant to innovative technology development corporations.
In 1998, he joined Telemac, an LA-based international communication services company where he was responsible for corporate strategy, international market development, and investor relationships. A strong desire to make an unshakable impact in the fight against cancer led Jim to found Advanced Medical Isotope Corporation (Vivos Inc.) in 2006 where he served as Chairman and CEO of Vivos Inc. through 2016. Earning the Richland Rotary Club and TRIDEC recognition for outstanding entrepreneurial contributions to this region’s economy, Jim also received a Federal Laboratory Consortium ‘Excellence’ award for Technology Transfer , ‘Injectable Radiogel for High-Dose Interstitial Radiation Therapy. During his decade at Vivos, he built a nuclear technology incubator, which included securing a robust patent portfolio, advancing several technologies through critical development milestones (including several for which the firm earned national awards) and became positioned to bring initial products/services to market.
Mr. Katzaroff has previously served on nonprofit boards including as Vice Chairman of Go Nuclear Inc, as Vice Chairman of the Fighting Children’s Cancer Foundation, as Board Member for Life Science Washington (formerly known as the Washington State Biotechnology and Biomedical Association), and as a Board Member of the Santa Barbara Boys and Girls Club.
Recent GSTC News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/17/2024 08:05:07 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/15/2024 04:33:13 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/19/2024 10:13:47 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 01/02/2024 09:21:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 05:32:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/17/2023 08:01:04 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:31:39 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM